Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Review Article
Author Details :
Volume : 8, Issue : 1, Year : 2021
Article Page : 17-28
https://doi.org/10.18231/j.ijpp.2021.004
Abstract
Cancer cachexia is complex, and can often occur in the presence of malnutrition, age-related changes in anabolism, physical deconditioning and comorbidity. These factors can also form potentially reversible components of the overall ‘cachexia burden’. Separating cancer cachexia from the effects and complications after cancer therapy is often difficult. This review aims to briefly describe cancer cachexia and these novel biological agents currently under investigation for the treatment of cancer –related cachexia. Treatment that can be reduces the muscle wasting which is resulting into cancer cachexia. The main aim of review
is to the potential treatment for cancer cachexia, which include Pharmacological, non-pharmacological, neutraceutical and investigational new treatments.
Keywords: Cachexia, Multimodal cachexia, Mediators of cachexia.
How to cite : Kalambe P S , Mangrulkarb S V , Jawald D T , Sonkusared M K , Behered S , Chaplec D R, Cancer cachexia: Current strategies and future perspectives. Indian J Pharm Pharmacol 2021;8(1):17-28
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.